HYPERFINE INC (HYPR)

Hyperfine, Inc. to Announce First Quarter 2024 Financial Results on May 13, 2024

Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical Conditions

Leading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study

HYPR Stock Earnings: Hyperfine Beats EPS, Misses Revenue for Q4 2023

HYPR stock results show that Hyperfine beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.

HYPR Stock Earnings: Hyperfine Beats EPS, Misses Revenue for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Hyperfine (NASDAQ:HYPR) just reported results for the fourth quarter of 2023.Hy...

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain...

Hyperfine, Inc. Collaborates with King’s College London to Demonstrate the Swoop® System and UNITY Project to The Princess Royal

Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024

Hyperfine, Inc. to Present at the Oppenheimer 34th Annual Healthcare Conference

Hyperfine, Inc. Announces Collaboration with Athletic Heart to Provide Vital Brain Health Imaging for Former Professional Athletes

Hyperfine, Inc. Celebrates Breadth of Swoop® System Data Presented at the 2024 International Stroke Conference and Provides an Update on Enrollment in ACTION PMR Stroke Observational Study

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

We're starting out the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!

Hyperfine, Inc. Launches AI-powered Brain Imaging Software for Enhanced Image Quality and Ease of Use

Jefferies starts Hyperfine at hold, says company still in early commercial stage

Jefferies initiated coverage of Hyperfine (HYPR) with a hold rating, stating the company was still in the early stages of commercializing its portable MRI product. Read more here.

Hyperfine, Inc. Announces Presentations on Clinical Advancements at RSNA 2023

Hyperfine, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference

Hyperfine files for $150M mixed securities shelf (NASDAQ:HYPR)

Hyperfine (HYPR) files a $150M mixed securities shelf prospectus, clarifying it is not an offer to sell.

Hyperfine, Inc. Reports Third Quarter 2023 Financial Results

Hyperfine, Inc. Reports Third Quarter 2023 Financial Results

GUILFORD, Conn., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system—the Swoop® system—today announced third quarter 2023 financial results and provided a business update.

Observational Study Finds That Hyperfine, Inc. Portable MR Brain Imaging System Assists Clinicians in Early Detection of Acute Brain Injury in ECMO Patients

Hyperfine, Inc. to Announce Third Quarter Financial Results on November 9, 2023

Hyperfine, Inc. Announces Promotions of Two Key Clinical Affairs Executives

Hyperfine, Inc. Receives FDA Clearance for Updated AI-powered Software with Improved Image Quality for All Swoop® System Sequences

Hyperfine, Inc. to Present at Gilmartin Group Emerging Growth Showcase

Hyperfine, Inc. Reports Second Quarter 2023 Financial Results

Hyperfine, Inc. Reports Second Quarter 2023 Financial Results

GUILFORD, Conn., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable, point-of-care MRI system, today announced second quarter 2023 financial results and provided a business update.

Enrollment Completed for HOPE PMR Pediatric Hydrocephalus Study Using Hyperfine, Inc. Portable MR Imaging® System

Hyperfine, Inc. to Announce Second Quarter Financial Results on August 14, 2023

Hyperfine, Inc. Announces Promotion of Tom Teisseyre, Ph.D. to Chief Operating Officer